Previous close | 39.40 |
Open | 39.40 |
Bid | 39.60 x 20000 |
Ask | 39.80 x 20000 |
Day's range | 39.40 - 39.40 |
52-week range | 23.20 - 39.80 |
Volume | |
Avg. volume | 0 |
Market cap | 1.49B |
Beta (5Y monthly) | 0.61 |
PE ratio (TTM) | 34.56 |
EPS (TTM) | 1.14 |
Earnings date | 21 May 2024 - 27 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 10 Dec 2018 |
1y target est | 82.00 |
NEW YORK, April 15, 2024--Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Krensavage Asset Management today sent the following message to a special committee evaluating Sun Pharmaceutical Industries Ltd.'s bid for Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y., January 25, 2024--TARO PROVIDES RESULTS FOR DECEMBER 31, 2023